Member Societies

• All
• Nov. 14 (Thu)
• Nov. 15 (Fri)
• Nov. 16 (Sat)

• KSGE
• KSG
• KASL
• KSNM
• KPBA
• KCHUGR
• KASID
• KSGC
• KSPGHAN
• Editor Session
• Insurance Policy Session
• [The 8th Joint Session between KDDW-TDDW-JDDW]

Symposium 01 : Distinguished papers of 2023-2024 in clinical and molecular hepatology English

Date / Time	Nov. 14 (Thu), 09:00-10:30
Room	Vista 1
Chair(s)	Han Chu Lee (University of Ulsan, Korea) Yoon Jun Kim (Seoul National University, Korea)
Speakers	09:00-09:10	CMH reports in 2024 Yeonjung Ha (CHA University, Korea)
	09:10-09:30	Most viewed article - Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: a nationwide study In Hee Kim (Jeonbuk National University, Korea)
	09:30-09:50	Highly cited article - Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: a DALY-based analysis of the global burden of disease 2019 study Seung Up Kim (Yonsei University, Korea)
	09:50-10:10	Notable article on clinical research - Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: a nationwide hepatitis C virus registry program Ming-Lung Yu (Kaohsiung Medical University, Taiwan)
	10:10-10:30	Notable article on basic/translational research - Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression Kyung Hyun Yoo (Sookmyung Women's University, Korea)

Presidential Lecture : Chung Yong Kim Memorial Lecture Korean

Date / Time	Nov. 14 (Thu), 11:10-11:40
Room	Vista 1
Chair(s)	Young Oh Kweon (Kyungpook National University, Korea)
Speakers	11:10-11:40	Recent update of MASLD Jin Mo Yang (The Catholic University of Korea, Korea)

Symposium 11 : Emerging issues in the management of portal hypertension English

Date / Time	Nov. 14 (Thu), 13:20-14:50
Room	Vista 1
Chair(s)	June Sung Lee (Inje University, Korea) Woo Jin Chung (Keimyung University, Korea)
Speakers	13:20-13:42	Noninvasive diagnosis of portal hypertension and its clinical applications Byeonggeun Song (Sungkyunkwan University, Korea)
	13:42-14:04	Albumin as a multiplayer in decompensated liver cirrhosis Yu Jun Wong (Changi General Hospital, Singapore)
	14:04-14:26	Personalized beta-blocker therapy in liver cirrhosis: pros and cons Moon Young Kim (Yonsei University Wonju, Korea)
	14:26-14:48	Evaluation and management of cardiovascular manifestations in end-stage liver diseases Jae Sik Park (The Catholic University of Korea, Korea)
	14:48-14:50	Q&A

Basic/Translational Symposium : Advancements in liver research: from experimental models to clinical insights and therapeutic targets Korean

Date / Time	Nov. 14 (Thu), 13:20-14:50
Room	Vista 3
Chair(s)	Dongho Choi (Hanyang University, Korea) Hyun Woong Lee (Yonsei University, Korea)
Speakers	13:20-13:42	Recent update of in vitro/ex vivo experiment for studying liver disease Young-Sun Lee (Korea University, Korea)
	13:42-14:04	Research insights into hepatic metabolism and carcinogenesis using human biospecimen Hyuk Soo Eun (Chungnam National University, Korea)
	14:04-14:26	Targeting gut-liver axis: new aspect of understanding chronic liver diseases Hail Kim (KAIST, Korea)
	14:26-14:48	Molecular connection between liver disease and cardiovascular disorders Myeong Jun Song (The Catholic University of Korea, Korea)
	14:48-14:50	Q&A

Symposium 12 : Careful insights for benign hepatic neoplasm English

Date / Time	Nov. 14 (Thu), 15:10-16:40
Room	Vista 1
Chair(s)	Sook-Hyang Jeong (Seoul National University, Korea) Soon Woo Nam (The Catholic University of Korea, Korea)
Speakers	15:10-15:32	Clinical and radiological implications of indeterminate hepatic nodules in patients with cirrhosis Seung-seob Kim (Yonsei University, Korea)
	15:32-15:54	Subtypes and their prognostic impact of Hepatocellular adenomas Valérie Paradis (Université Paris Cité, France)
	15:54-16:16	Hepatic angiomyolipoma and perivascular epithelioid cell tumor family in the liver: dangers of misdiagnosis with HCC In Hye Song (University of Ulsan, Korea)
	16:16-16:38	Precursor lesions of cholangiocarcinoma: Hepatologist needs to know Yasuni Nakanuma (Fukui Prefecture Saiseikai Hospital, Japan)
	16:38-16:40	Q&A

Symposium 14 : Sarcopenia in liver diseases: from molecular insights to clinical strategies English

Date / Time	Nov. 15 (Fri), 08:30-10:00
Room	Vista 2
Chair(s)	Tae Hun Kim (Ewha Womans University, Korea) Yu Jun Wong (Changi General Hospital, Singapore)
Speakers	08:30-08:52	Comprehensive assessment of sarcopenia and frailty: how and by which tools? Bo Kyung Koo (Seoul National University, Korea)
	08:52-09:14	Sarcopenia in cirrhosis: from pathogenesis to prognosis Sae Kyung Joo (Seoul National University, Korea)
	09:14-09:36	Sarcopenia in MASLD : an altered liver-muscle crosstalk Sung Hwan Yoo (Yonsei University, Korea)
	09:36-09:58	Multidisciplinary therapeutic strategies for sarcopenia Do Seon Song (The Catholic University of Korea, Korea)
	09:58-10:00	Q&A

Symposium 17 : Update and latest advances in systemic treatment for HCC English

Date / Time	Nov. 15 (Fri), 10:20-11:50
Room	Vista 2
Chair(s)	Valérie Paradis (Université Paris Cité, France) Ju Hyun Shim (University of Ulsan, Korea)
Speakers	10:20-10:42	Adverse events of atezolizumab and bevacizumab in HCC: risk factors and dose modification Sangyoun Hwang (Dongnam Institute of Radiological & Medical Sciences (DIRAMS), Korea)
	10:42-11:04	Imaging biomarkers for response evaluation of atezolizumab and bevacizumab in HCC Kyowon Gu (Sungkyunkwan University, Korea)
	11:04-11:26	Adjuvant and combined roles of systemic treatment in HCC Yu Rim Lee (Kyungpook National University, Korea)
	11:26-11:48	Blood- and tissue-based tools to guide optimal systemic treatment in HCC Stephen Lam Chan (The Chinese University of Hong Kong, Hong Kong)
	11:48-11:50	Q&A

Free Paper 10 : Liver 01 English

Date / Time	Nov. 15 (Fri), 13:20-14:00
Room	Vista 2
Chair(s)	Do Young Kim (Yonsei University, Korea) Nae-Yun Heo (Inje University, Korea)
Speakers	13:20-13:30	Revisiting the Steatosis-Associated Fibrosis Estimator score in Young Asian Subjects with Steatotic Liver Disease and Consideration for Population Variability Jiwon Yang (University of Ulsan, Korea)
	13:30-13:40	Prevalence and incidence of QT prolongation in metabolic dysfunction-associated steatotic liver disease a longitudinal study from the UK Biobank Joo Hyun Oh (Eulji University, Korea)
	13:40-13:50	Association between metabolic dysfunction-associated steatotic liver disease and atrial fibrillation: a nationwide cohort study Yoon Sung Min (Dong-A University, Korea)
	13:50-14:00	Genetic association of lipids and lipid-lowering drug target genes with autoimmune liver disease, chronic viral hepatitis and cirrhosis Tao Yang (The Affiliated Hospital of Southwest Medical University, China)

Free Paper 11 : Liver 02 English

Date / Time	Nov. 15 (Fri), 14:00-14:50
Room	Vista 2
Chair(s)	Young Nyun Park (Yonsei University, Korea) Bo Hyun Kim (National Cancer Center, Korea)
Speakers	14:00-14:10	In-Hospital Hepatitis C Virus Alarm System: A Strategy to improve Linkage to Care for HCV Jaehong Jeong (Daegu Catholic University, Korea)
	14:10-14:20	Histological spectrum of chronic hepatitis B virus patients with normal serum ALT and detectable HBV DNA Abul Hayat Manik (Dhaka Medical College Hospital, Bangladesh)
	14:20-14:30	Performance evaluation of highly-sensitive hepatitis B surface antigen and core-related antigen in the clinical practice Sung Hwan Yoo (Yonsei University, Korea)
	14:30-14:40	Clinical characteristics of pediatric autoimmune hepatitis in Korea Jeong Eun Ahn (Seoul National University, Korea)

Free Paper 14 : Liver 03 English

Date / Time	Nov. 15 (Fri), 15:10-16:00
Room	Vista 2
Chair(s)	Soung Won Jeong (Soonchunhyang University, Korea) Geum-Youn Gwak (Sungkyunkwan University, Korea)
Speakers	15:10-15:20	Characteristics and Outcomes of Hepatocellular Carcinoma Related to MASLD versus NAFLD Sung Won Chung (University of Ulsan, Korea)
	15:20-15:30	NOX2 induces Hepatocellular carcinoma development by regulating EMT signaling through SREBP2 Hei-Gwon Choi (Chungnam National University, Korea)
	15:30-15:40	The Role of FOXO1 in Post-Transplant Recurrence of Hepatocellular Carcinoma: A Study on Diagnostic and Therapeutic Targets Chao Wang (Zhejiang University, China)
	15:40-15:50	Development and Validation of a Multimarker Panel for the Early Diagnosis of Hepatocellular Carcinoma Using Quantitative Proteomics Approach Moon Haeng Hur (Seoul National University, Korea)
	15:50-16:00	Geriatric Nutritional Risk Index as a prognostic factor in patients with hepatocellular carcinoma: Based on Korea Nationwide Cancer Registry Heechul Nam (The Catholic University of Korea, Korea)

USG01 : Abdominal US training specialist 1 Korean

Date / Time	Nov. 16 (Sat), 08:30-10:00
Room	Walker 1
Chair(s)	Sang Gyune Kim (Soonchunhyang University, Korea)
Speakers	08:30-08:50	Preparing for ultrasound education: tips and recommendations Seul Ki Han (Yonsei University Wonju, Korea)
	08:50-09:10	Learning goal and outcomes of ultrasound education Jeong Eun Song (Daegu Catholic University, Korea)
	09:10-09:30	Echocardiography education: what to imitate? Dae-Hee Kim (University of Ulsan, Korea)
	09:30-09:50	A comparison of point of care ultrasound and conventional ultrasound Young Soon Cho (Soonchunhyang University, Korea)
	09:50-10:00	Q&A

USG02 : Abdominal US training specialist 2 Korean

Date / Time	Nov. 16 (Sat), 10:20-11:50
Room	Walker 1
Chair(s)	Yun Soo Kim (Gachon University, Korea)
Speakers	10:20-10:40	Local ablation for patients with hepatocellular carcinoma: Korean expert consensus-based practice Dong Ho Lee (Seoul National University, Korea)
	10:40-11:00	A comparison of endoscopic ultrasound and transabdominal ultrasound in pancreatobiliary disease Huapyong Kang (Gachon University, Korea)
	11:00-11:20	Liver application of fusion imaging: real-time virtual sonography (RVS) Min Woo Lee (Sungkyunkwan University, Korea)
	11:20-11:40	Noninvasive tests (NITS) for hepatic fibrosis: us-based elastography Ji Won Han (The Catholic University of Korea, Korea)
	11:40-11:50	Q&A